Grünenthal


Grünenthal is a science-based, fully integrated pharmaceutical company focused on development, commercialization and research of treatments for pain and related disorders. The company conducts internal R&D concentrated on neuropathic pain, chronic post-surgical pain, chronic low-back pain and osteoarthritis, runs global commercialization activities, and engages in partnerships and patient- and professional-facing initiatives.

Industries

health-care
manufacturing
medical
pharmaceutical

Nr. of Employees

Very Large (1000+)

Grünenthal

Puteaux, Ile-de-France, France, Europe


Products

Esomeprazole formulations (gastro-resistant granules and tablets)

Esomeprazole delivered as gastro‑resistant granules for suspension and gastro‑resistant tablets in multiple strengths.

Transdermal capsaicin patch

Topical patch formulation delivering capsaicin for localized neuropathic pain management.

Sublingual fentanyl tablets

Sublingual tablet formulations of fentanyl for management of breakthrough pain in selected patients.

Nasal fentanyl spray

Nasal spray fentanyl formulations in multiple strengths for acute pain episodes.

Injectable testosterone solution

Long‑acting injectable testosterone formulation for specified endocrine indications.

Various opioid and non-opioid analgesic formulations

Range of analgesic products including oral tramadol formulations (immediate and prolonged-release), paracetamol combinations, and other analgesics across solid, liquid and injectable forms.


Services

Strategic partnering and collaboration

Partnering with academic and industry organisations to co‑develop therapies and share scientific expertise.

Compassionate use program management

Operational management and data collection for compassionate prescription frameworks and monitored patient access.

Expertise Areas

  • Pain therapeutics (neuropathic pain, post-surgical chronic pain, low-back pain, osteoarthritis)
  • Clinical development and validation
  • Translational medicine and target identification
  • Formulation and drug-delivery development
  • Show More (4)

Key Technologies

  • Translational science
  • Clinical trial design and execution
  • Formulation development (oral solid dose, extended‑release)
  • Transdermal patch technology
  • Show More (5)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.